10-71805998-G-T
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1_ModeratePP5_Very_Strong
The NM_022124.6(CDH23):c.8064+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_022124.6 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 12Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Usher syndrome type 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 1DInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDH23 | NM_022124.6 | c.8064+1G>T | splice_donor_variant, intron_variant | Intron 56 of 69 | ENST00000224721.12 | NP_071407.4 | ||
| CDH23 | NM_001171933.1 | c.1344+1G>T | splice_donor_variant, intron_variant | Intron 9 of 22 | NP_001165404.1 | |||
| CDH23 | NM_001171934.1 | c.1344+1G>T | splice_donor_variant, intron_variant | Intron 9 of 21 | NP_001165405.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CDH23 | ENST00000224721.12 | c.8064+1G>T | splice_donor_variant, intron_variant | Intron 56 of 69 | 5 | NM_022124.6 | ENSP00000224721.9 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 144246Hom.: 0 Cov.: 31
GnomAD2 exomes AF: 0.00 AC: 0AN: 232862 AF XY: 0.00
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 801642Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 412004
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 144246Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 70194
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change affects a donor splice site in intron 56 of the CDH23 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CDH23 are known to be pathogenic (PMID: 11138009, 21940737). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with Usher syndrome (PMID: 35020051). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 517297). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 11138009) -
Pituitary adenoma 5, multiple types Pathogenic:1
- -
Rare genetic deafness Pathogenic:1
The c.8064+1G>T variant in CDH23 has not been previously reported in individuals with hearing loss or Usher syndrome, or in large population studies. This varia nt occurs in the invariant region (+/- 1,2) of the splice consensus sequence and is predicted to cause altered splicing leading to an abnormal or absent protein . Loss of CDH23 function is an established mechanism of Usher syndrome. In summa ry, this variant meets criteria to be classified as pathogenic for Usher syndrom e in an autosomal recessive manner based on its predicted impact on the protein and extremely low frequency in the general population. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at